Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1982-06-09
1984-10-02
Robinson, Douglas W.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
424343, A61K 3111, A61K 31045
Patent
active
044748175
ABSTRACT:
Cataract formation in mammalian lenses can be prevented or reversed by applying a solution of an aldehyde, an acrylamide or a glycol to the lens under conditions that permit the solution to interact with the lens constituents.
REFERENCES:
patent: 3461210 (1969-08-01), Fossel
Chem. Abst. 76, 149,208(a) (1972)-Ihglio.
Chem. Abst. 80, 41006(b) (1974)-Newton et al.
Chem. Abst. 92, 73927(s) (1980)-Benedek et al.
Chem. Abst. 93, 108,038(c) (1980)-Clark et al.
Benedek George B.
Clark John I.
Mengel Loretta S.
Cook Paul J.
Massachusetts Institute of Technology
Robinson Douglas W.
Smith, Jr. Arthur A.
LandOfFree
Process for preventing or reversing cataract formation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process for preventing or reversing cataract formation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for preventing or reversing cataract formation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-526724